Status:
COMPLETED
An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis B Infection
Hepatitis C Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The goal of the proposed study is to use the HBV vaccine as a model for a future HIV vaccine trial, examining the efficacy of community-based outreach intervention as well as an accelerated vaccine sc...
Detailed Description
This project will evaluate an HBV vaccination program as a model for future HIV vaccine efficacy trials in a community-based study of drug users. Two components will be analyzed in an effort to increa...
Eligibility Criteria
Inclusion
- using cocaine/heroin in last 7 days, age over 18 years old from two matched in population size, income and demographic communities, known with high rate of drug using and STD; competent to consent for urine drug screening and viral markers (anti-HIV, HBsAg/anti-HBs, anti-HCV) testing; those negative for HIV/HBV will be contacted for HB vaccination study.
Exclusion
- age under 18 or not from the target communities, negative for urine drug test.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
1260 Patients enrolled
Trial Details
Trial ID
NCT00841477
Start Date
January 1 2004
End Date
December 1 2009
Last Update
January 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas-HSC at Houston, School of Public Health
Houston, Texas, United States, 77030